Last update:
Oncology news
Overcoming ovarian cancer's resistance to immunotherapy
Cells in our immune system are best known for providing security against external invaders such as bacteria and viruses. These immune cells also guard against internal threats, including cancerous tumors. Different forms ...
7 hours ago
0
0
Light-sensing genes may connect three childhood tumor types
Research uncovering the origin of pineoblastoma, a rare pediatric brain tumor, has also revealed a dependency across multiple brain tumor types that share a similar molecular program. Scientists at St. Jude Children's Research ...
7 hours ago
0
0
Combination therapy shows promising efficacy in aggressive leukemia
Acute myeloid leukemia (AML) is a particularly aggressive form of blood cancer that usually progresses rapidly if swift and intensive treatment is not applied. Although the disease can often be contained by chemotherapy (remission), ...
5 hours ago
0
0
AI blood test detects early pancreatic cancer with up to 94% accuracy
A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a simple blood sample to detect pancreatic cancer at its earliest stages—when treatment is most effective—achieving ...
12 hours ago
0
1
Study points to potential new therapies for hard-to-treat lung cancers
Findings from a study led by researchers at The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC–James) support the potential of new therapies ...
8 hours ago
0
0
MRI supplemental to digital breast tomosynthesis averts additional breast cancer deaths
For women aged 40 years and older with extremely dense breasts, digital breast tomosynthesis (DBT) with supplemental magnetic resonance imaging (MRI) averts additional breast cancer deaths and results in more false-positive ...
5 hours ago
0
0
AAAAI: No increase seen in asthma exacerbations with ICI use for melanoma, renal cell carcinoma
For patients with asthma, receipt of immune checkpoint inhibitor (ICI) therapy for melanoma or renal cell carcinoma is not associated with an increased risk for exacerbations, according to a study presented at the annual ...
7 hours ago
0
0
No decline in childhood cancer survival in Sweden during the pandemic
During the COVID-19 pandemic, there were global concerns that children with cancer might experience delayed diagnoses and disruptions to treatment, which in turn could worsen prognosis. However, a new register-based study ...
9 hours ago
0
0
Cryotherapy could be a game changer for patients with early-stage kidney cancer
Today, small kidney tumors are most often treated with a minor operation in which all or part of the kidney is removed. However, in many cases, these small tumors can be treated with targeted cryotherapy, which destroys the ...
12 hours ago
0
0
Study maps US diabetes–cancer hotspots
A new University of Kentucky study has mapped areas across the U.S. where high rates of diabetes and deaths from diabetes-related cancers overlap. The UK Markey Cancer Center and Barnstable Brown Diabetes Center research ...
15 hours ago
0
0
GI cancers to double by 2050, experts warn
Gastrointestinal cancer cases are expected to double worldwide by 2050, according to a multi-institutional study co-led by Cedars-Sinai. The projections, based on 2022 data and published in the journal Cancer, conclude that ...
17 hours ago
0
0
Molecular target drives immunogenicity in cancer immunotherapy
Researchers at the National University of Singapore (NUS) have identified a protein called tyrosine phosphatase 1B (PTP1B) as a potential "switch" that can modulate a type of cancer cell death known as immunogenic cell death ...
18 hours ago
0
0
AI could help predict your risk of breast cancer in the next four years
An artificial intelligence (AI) algorithm used to detect breast cancer in screening scans has been adapted into a risk score that estimates a woman's risk of developing breast cancer over the next four years, according to ...
Mar 4, 2026
0
1
Engineered CAR-T cells block key protein to break solid tumors' immune shield
UCLA scientists have developed a next-generation CAR-T cell therapy that can overcome the immunosuppressive tumor microenvironment, a protective shield that tumors use to weaken immune cells, block their attack, and fuel ...
Mar 4, 2026
0
0
Why some tiny tumors vanish and others grow: Discovery could help treat cancer at very earliest stages
Cambridge scientists have shown that when tumors first emerge, interactions with healthy cells in the underlying supportive tissue determine their ability to survive, grow, and progress to advanced stages of disease.
Mar 4, 2026
0
0
Good vibrations: Playing music to cells reduces laryngeal cancer aggressiveness in lab tests
The continuous movement of the vocal cords weakens and eventually stops as laryngeal cancer progresses. Researchers have, for the first time, discovered that restoring cellular vibration reduces the aggressiveness of advanced ...
Mar 4, 2026
0
0
An existing, FDA-approved drug could stem the spread of breast cancer
Cancer spreads (metastasizes) when tumor cells shed from a primary solid tumor (for example, in the breast) and embed in other organs, such as the lung, liver, and brain, and begin to grow. Most approaches to prevent this ...
Mar 4, 2026
0
0
One-hour saliva test spots biomarker linked to several cancers
QUT researchers have developed a simple one-hour saliva test for a protein biomarker that has been linked with oral, colon and pancreatic cancers. The findings are published in the journal Talanta.
Mar 4, 2026
0
0
Glucose drives STAT3 activation in colorectal cancer cells, leading to tumor growth
Colorectal cancer is the third most common cancer in the United States. Although screening has led to a decrease in incidence over the past 20 years, early-onset colorectal cancer has been rising. Despite advances in surgery ...
Mar 4, 2026
0
0
New AI tool predicts best pancreatic cancer treatment
A new tool co-developed by investigators from Cedars-Sinai Health Sciences University can predict which of two available chemotherapy options for pancreatic cancer would be more effective for an individual patient.
Mar 4, 2026
0
0
Distinct tumor-immune ecologies can help predict immunotherapy response in lung cancer
Researchers at Moffitt Cancer Center have identified distinct spatial tumor–immune ecosystems that predict whether patients with advanced non–small-cell lung cancer will benefit from immunotherapy. The findings, published ...
Mar 4, 2026
0
0
CAR T-cell therapy improves survival in relapsed or refractory lymphoma
CAR T-cell immunotherapy improved progression-free and overall survival in patients with relapsed or refractory marginal zone lymphoma, according to a recent clinical trial published in The Lancet. Marginal zone lymphoma ...
Mar 4, 2026
0
0
Open source cancer database created for easier disease study
Researchers from the Johns Hopkins Kimmel Cancer Center and The Johns Hopkins University have created a novel database structure that allows investigators anywhere to more easily study multiple types of cancer data—including ...
Mar 4, 2026
0
0
Gaps in lung cancer treatment persist, study finds
In recent decades, lung cancer treatment has been transformed—new surgeries, new radiation techniques, and dramatically improved outcomes. But according to new research from Yale, published in JAMA Network Open, one thing ...
Mar 4, 2026
0
0
A questionnaire allows for reliable measurement of cancer patients' concerns
The fear that cancer will progress or worsen is one of the most common concerns among people living with the disease. Identifying and measuring this concern is key to providing appropriate psychological care and improving ...
Mar 4, 2026
0
0
